General Information of Disease (ID: DISKXQ7J)

Disease Name Bloom syndrome
Synonyms
microcephaly, growth restriction, and increased sister chromatid exchange 1; MGRISCE1; growth deficiency, sun-sensitive, telangiectatic, hypo and hyperpigmented skin, predisposition to malignancy and chromosomal instability; BS; BLM; BLS; congenital telangiectatic erythema; BSyn; congenital telangiectatic erythema syndrome; Bloom-Torre-Machacek syndrome; Bloom syndrome
Definition
Bloom syndrome (BSyn) is a rare chromosomal breakage syndrome characterized by a marked genetic instability associated with pre- and postnatal growth retardation, facial sun-sensitive telangiectatic erythema, increased susceptibility to infections, and predisposition to cancer.
Disease Hierarchy
DISQCXZX: Disorder of development or morphogenesis
DISXNHQG: Microcephaly, growth restriction and increased sister chromatid exchange
DIS6SVEE: Syndromic disease
DISCPWH9: Autosomal recessive disease
DIS9XD9A: Hematologic disease
DISM5BB5: Chromosomal disorder
DISYJQB2: Hereditary photodermatosis
DISKXQ7J: Bloom syndrome
Disease Identifiers
MONDO ID
MONDO_0008876
MESH ID
D001816
UMLS CUI
C0005859
OMIM ID
210900
MedGen ID
2685
Orphanet ID
125
SNOMED CT ID
4434006

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 8 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
BRIP1 TTZV7LJ moderate Biomarker [1]
CDA TTQ12RK moderate Altered Expression [2]
FANCF TTNZKFJ moderate Biomarker [3]
GP1BA TTVB0Q9 moderate Altered Expression [4]
GPR17 TTMPART moderate Altered Expression [5]
TOP2B TT4NVEM moderate Biomarker [6]
FES TTLBY21 Strong Biomarker [7]
WRN TT2H5WQ Strong Biomarker [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DTT(s)
This Disease Is Related to 40 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ADAM15 OTZ7VLTP moderate Biomarker [9]
ANKH OTCN25R5 moderate Biomarker [10]
DDX1 OT3U8FD0 moderate Biomarker [11]
DMC1 OT1FHMW4 moderate Biomarker [12]
FANCB OTMZTXB5 moderate Genetic Variation [13]
GYPB OTESHUIX moderate Genetic Variation [14]
GYPE OTBHAG6A moderate Genetic Variation [14]
KRT10 OTSVRD3Q moderate Biomarker [15]
MS4A12 OTUCF3GW moderate Genetic Variation [16]
NREP OT2AZPKK moderate Altered Expression [17]
PITX3 OTE2KT8P moderate Altered Expression [18]
POLD4 OTG578YH moderate Altered Expression [19]
RAD51D OTKOU5XN moderate Biomarker [20]
RAD54L OTEGMAKG moderate Genetic Variation [21]
RIF1 OTPE49OE moderate Biomarker [11]
RMI2 OTA0HP4S moderate Biomarker [22]
SLX4 OTF6236I moderate Biomarker [23]
SPIDR OTO1OII0 moderate Biomarker [24]
SUMO2 OT1Y5IKN moderate Genetic Variation [25]
SUMO3 OTTUJQJ1 moderate Genetic Variation [25]
TCHP OTVDMHSY moderate Biomarker [26]
TNMD OTHLVA9G moderate Biomarker [27]
TOP3A OT3CKUI9 moderate Genetic Variation [28]
APOBEC3C OTPL0AI1 Strong Genetic Variation [29]
ARID5A OTQT7CG9 Strong Biomarker [30]
CYCS OTBFALJD Strong Biomarker [31]
DNA2 OT4DJFFU Strong Genetic Variation [32]
EXO1 OTI87RS5 Strong Biomarker [32]
FANCC OTTIDM3P Strong Genetic Variation [33]
FANCM OTNJG99Z Strong Biomarker [34]
GYPA OTABU4YV Strong Biomarker [35]
HFM1 OTHV3EFE Strong Biomarker [36]
IFT80 OTMH0MBI Strong Genetic Variation [37]
LBR OT1HG3HG Strong Biomarker [38]
LTBP4 OTC8WL2V Strong Altered Expression [39]
MUS81 OTVZ4E60 Strong Biomarker [23]
RECQL4 OT59LSW7 Strong Biomarker [8]
SMR3A OT6NAJJI Strong Genetic Variation [29]
TOPBP1 OT6UPZPD Strong Biomarker [40]
BLM OTEJOAJX Definitive Autosomal recessive [41]
------------------------------------------------------------------------------------
⏷ Show the Full List of 40 DOT(s)

References

1 Fanconi anemia and Bloom's syndrome crosstalk through FANCJ-BLM helicase interaction.Trends Genet. 2012 Jan;28(1):7-13. doi: 10.1016/j.tig.2011.09.003. Epub 2011 Oct 23.
2 Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.Clin Cancer Res. 2017 Apr 15;23(8):2116-2126. doi: 10.1158/1078-0432.CCR-16-0626. Epub 2016 Sep 6.
3 FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia.Mol Cell. 2009 Dec 25;36(6):943-53. doi: 10.1016/j.molcel.2009.12.006.
4 Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome.Chin J Integr Med. 2008 Dec;14(4):267-73. doi: 10.1007/s11655-008-0267-1. Epub 2008 Dec 12.
5 Cangrelor alleviates pulmonary fibrosis by inhibiting GPR17-mediated inflammation in mice.Int Immunopharmacol. 2018 Sep;62:261-269. doi: 10.1016/j.intimp.2018.06.006. Epub 2018 Jul 23.
6 TopBP1 interacts with BLM to maintain genome stability but is dispensable for preventing BLM degradation.Mol Cell. 2015 Mar 19;57(6):1133-1141. doi: 10.1016/j.molcel.2015.02.012.
7 Molecular genetics of Bloom's syndrome.Hum Mol Genet. 1996;5 Spec No:1457-63. doi: 10.1093/hmg/5.supplement_1.1457.
8 Bloom's syndrome: Why not premature aging?: A comparison of the BLM and WRN helicases.Ageing Res Rev. 2017 Jan;33:36-51. doi: 10.1016/j.arr.2016.05.010. Epub 2016 May 26.
9 Melanoma cell-derived vascular endothelial growth factor induces endothelial tubulogenesis within fibrin gels by a metalloproteinase-mediated mechanism.Eur J Cell Biol. 2006 Nov;85(11):1167-77. doi: 10.1016/j.ejcb.2006.07.003. Epub 2006 Sep 1.
10 Biological activities of phosphocitrate: a potential meniscal protective agent.Biomed Res Int. 2013;2013:726581. doi: 10.1155/2013/726581. Epub 2013 Jul 11.
11 Role for RIF1-interacting partner DDX1 in BLM recruitment to DNA double-strand breaks.DNA Repair (Amst). 2017 Jul;55:47-63. doi: 10.1016/j.dnarep.2017.05.001. Epub 2017 May 13.
12 Expression and nuclear localization of BLM, a chromosome stability protein mutated in Bloom's syndrome, suggest a role in recombination during meiotic prophase.J Cell Sci. 2000 Feb;113 ( Pt 4):663-72. doi: 10.1242/jcs.113.4.663.
13 Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies.Cancer Genet Cytogenet. 2001 Jul 1;128(1):39-42. doi: 10.1016/s0165-4608(01)00392-2.
14 Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome.Proc Natl Acad Sci U S A. 1989 Jan;86(2):670-4. doi: 10.1073/pnas.86.2.670.
15 Molecular advances in genetic skin diseases.Curr Opin Pediatr. 2002 Aug;14(4):419-25. doi: 10.1097/00008480-200208000-00011.
16 Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.Neoplasma. 2017;64(1):65-73. doi: 10.4149/neo_2017_108.
17 P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-1, -2, and -3 Translation.Am J Respir Cell Mol Biol. 2019 Feb;60(2):221-231. doi: 10.1165/rcmb.2018-0028OC.
18 Lung inflammation after bleomycin treatment in mice: Selection of an accurate normalization strategy for gene expression analysis in an ex-vivo and in-vitro model.Int J Biochem Cell Biol. 2017 Jul;88:145-154. doi: 10.1016/j.biocel.2017.05.016. Epub 2017 May 16.
19 The Bloom's syndrome helicase (BLM) interacts physically and functionally with p12, the smallest subunit of human DNA polymerase delta.Nucleic Acids Res. 2008 Sep;36(16):5166-79. doi: 10.1093/nar/gkn498. Epub 2008 Aug 5.
20 Functional interaction between the Bloom's syndrome helicase and the RAD51 paralog, RAD51L3 (RAD51D).J Biol Chem. 2003 Nov 28;278(48):48357-66. doi: 10.1074/jbc.M308838200. Epub 2003 Sep 15.
21 hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas.Cancer Genet Cytogenet. 2000 Jan 15;116(2):142-7. doi: 10.1016/s0165-4608(99)00122-3.
22 Loss of RMI2 Increases Genome Instability and Causes a Bloom-Like Syndrome.PLoS Genet. 2016 Dec 15;12(12):e1006483. doi: 10.1371/journal.pgen.1006483. eCollection 2016 Dec.
23 Aberrant chromosome morphology in human cells defective for Holliday junction resolution.Nature. 2011 Mar 31;471(7340):642-6. doi: 10.1038/nature09790. Epub 2011 Mar 13.
24 Scaffolding protein SPIDR/KIAA0146 connects the Bloom syndrome helicase with homologous recombination repair.Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10646-51. doi: 10.1073/pnas.1220921110. Epub 2013 Mar 18.
25 Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification.J Biol Chem. 2008 Oct 24;283(43):29405-15. doi: 10.1074/jbc.M803632200. Epub 2008 Aug 15.
26 Absence of p53 enhances growth defects and etoposide sensitivity of human cells lacking the Bloom syndrome helicase BLM.DNA Cell Biol. 2007 Jul;26(7):517-25. doi: 10.1089/dna.2007.0578.
27 The role of the secondary phloem during the development of the grapevine Berry Shrivel ripening disorder.Micron. 2019 Jan;116:36-45. doi: 10.1016/j.micron.2018.09.012. Epub 2018 Sep 27.
28 Mutations in TOP3A Cause a Bloom Syndrome-like Disorder.Am J Hum Genet. 2018 Aug 2;103(2):221-231. doi: 10.1016/j.ajhg.2018.07.001. Epub 2018 Jul 26.
29 Percutaneous interventional management of biliary complications after pediatric liver transplantation: A 16-year single-institution experience.Pediatr Transplant. 2017 Feb;21(1). doi: 10.1111/petr.12837. Epub 2016 Oct 30.
30 Arid5a-deficient mice are highly resistant to bleomycin-induced lung injury.Int Immunol. 2017 Feb 1;29(2):79-85. doi: 10.1093/intimm/dxx004.
31 Long term follow-up of Behet's syndrome patients treated with cyclophosphamide.Rheumatology (Oxford). 2020 Sep 1;59(9):2264-2271. doi: 10.1093/rheumatology/kez598.
32 RPA Phosphorylation Inhibits DNA Resection.Mol Cell. 2019 Jul 11;75(1):145-153.e5. doi: 10.1016/j.molcel.2019.05.005. Epub 2019 May 29.
33 Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.PLoS Genet. 2012 Sep;8(9):e1002894. doi: 10.1371/journal.pgen.1002894. Epub 2012 Sep 27.
34 Defining the molecular interface that connects the Fanconi anemia protein FANCM to the Bloom syndrome dissolvasome.Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4437-42. doi: 10.1073/pnas.1117279109. Epub 2012 Mar 5.
35 In vivo somatic mutations in Werner's syndrome.Hum Genet. 1998 Oct;103(4):405-10. doi: 10.1007/s004390050841.
36 The Werner syndrome RECQ helicase targets G4 DNA in human cells to modulate transcription.Hum Mol Genet. 2016 May 15;25(10):2060-2069. doi: 10.1093/hmg/ddw079. Epub 2016 Mar 16.
37 Mutations in IFT80 cause SRPS Type IV. Report of two families and review. Am J Med Genet A. 2019 Apr;179(4):639-644. doi: 10.1002/ajmg.a.61050. Epub 2019 Feb 14.
38 Dominant negative effect of novel mutations in pyruvate kinase-M2.DNA Cell Biol. 2004 Jul;23(7):442-9. doi: 10.1089/1044549041474797.
39 Increased expression of latent TGF--binding protein 4 affects the fibrotic process in scleroderma by TGF-/SMAD signaling.Lab Invest. 2017 May;97(5):591-601. doi: 10.1038/labinvest.2017.20. Epub 2017 Mar 6.
40 Structural Insight into BLM Recognition by TopBP1.Structure. 2017 Oct 3;25(10):1582-1588.e3. doi: 10.1016/j.str.2017.08.005. Epub 2017 Sep 14.
41 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.